CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • ASCO19 Day 5 Update: CAR T Cells for Pleural Cancers and More Melanoma News

    The final day of ASCO19 covered CAR T cells for pleural cancers and long-term updates on several…

    June 5, 2019| Arthur N. Brodsky, PhD
  • ASCO19 Day 4 Update: Kidney Cancer, Liver Cancer, Stomach Cancer, Esophageal Cancer, and Melanoma

    The fourth day at ASCO19 highlighted immunotherapy strategies for patients with kidney cancer, liver cancer, stomach cancer,…

    June 3, 2019| Arthur N. Brodsky, PhD
  • ASCO19 Day 3 Update: Immunotherapy for Brain Cancer, Ovarian Cancer, Lung Cancer, and Patients with HIV

    The third day at ASCO19 highlighted immunotherapy strategies for patients with brain cancer, ovarian cancer, lung cancer,…

    June 3, 2019| Arthur N. Brodsky, PhD
  • ASCO19 Day 2 Update: Biomarkers in Checkpoint Immunotherapy, Targeting Macrophages, and Cellular Immunotherapies

    The second day at ASCO19 highlighted biomarkers that may have value in the context of PD-1 checkpoint…

    June 2, 2019| Arthur N. Brodsky, PhD
  • ASCO19 Day 1 Update: Lung Cancer, Head and Neck Cancer, and the Cost of Immunotherapy

    The opening day at ASCO19 discussed various immunotherapy combinations for head and neck cancer, a bispecific antibody…

    June 1, 2019| Arthur N. Brodsky, PhD
  • ASCO19 Preview: Caring for Every Patient, Learning from Every Patient

    Effective treatments and patient response are the focus of the world’s largest clinical cancer conference when it…

    May 24, 2019| Arthur N. Brodsky, PhD
  • AACR19 Recap: Leveraging the Latest Science to Improve Clinical Care

    AACR19 highlighted incredible advances in our efforts to leverage cutting-edge science in order to improve medical treatment for…

    April 5, 2019| Arthur N. Brodsky, PhD
  • AACR19 Day 5 Update: Bispecific Antibodies, the Importance of “Helper” T Cells, and the Lloyd J. Old Award Lecture

    Scientists tackled novel immunotherapy strategies that could potentially enable more patients with more types of cancer to…

    April 3, 2019| Arthur N. Brodsky, PhD
  • AACR19 Day 4 Update: The Microbiome, Immunotherapy Biomarkers, and New Immune Targets

    Day 4 of AACR19 explored the microbiome and its impact on cancer treatment, revealed insights into immunotherapy…

    April 2, 2019| Arthur N. Brodsky, PhD
Previous Page
1 2 3 4 5 6 … 15
Next Page

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute